Category

UF Startup

VetGuardian Is Working on Wireless Veterinary Care

Vik Ramprakash, CEO of UF startup Structured Monitoring Products Inc, has developed a solution called VetGuardian, a wireless device that sits a few feet away from the animal and requires no connection points to monitor the animal's vitals.

COVID-19 Fighting Antibodies Developed in Alachua Sent to Clinical Trials

Supporting our troops: an Alachua company works to keep our soldiers safe from COVID-19. Here's what UF startup and UF Innovate | Sid Martin Biotech alum Ology Bioservices Inc., a biologics contract development and manufacturing organization (CDMO), is doing on the front lines of the pandemic.

Ology Bioservices Signs Built-to-Suit Lab Space, Adding 43,000 Square Feet to Headquarters

Avison Young facilitated a 42,500-square-foot lease agreement between Concept Companies and Ology Bioservices, a UF startup and UF Innovate | Sid Martin Biotech alum, for a new built-to-suit lab space on the heels of a federal government contract for the company to expand production capabilities, including vaccines and therapeutics for COVID-19 once finalized.

Atsena Therapeutics Raises $55 Million Series A Financing to Advance LCA1 Gene Therapy Clinical Program, Two Preclinical Assets, and Novel Capsid Development for Ocular Diseases

UF startup Atsena Therapeutics, a clinical-stage gene therapy company focused on bringing the life-changing power of genetic medicine to reverse or prevent blindness, announced it has closed an oversubscribed $55 million Series A financing led by Sofinnova Investments with participation from additional new investors Abingworth and Lightstone Ventures.

High-Resolution Cameras in Space for a European Maritime Surveillance System

Observe the Earth from space to improve the defense of the European Union. With this objective in mind, UF startup and UF Innovate | The Hub resident company SATLANTIS, a provider of high-performance payload technologies for Earth observation and remote sensing, is leading a European project to develop critical technologies with which to implement a maritime surveillance mission.

Panbela Therapeutics, Inc. Completes Enrollment in Its Phase 1b Trial Investigating SBP-101 Combination Therapy for First-Line Metastatic Pancreatic Cancer

Panbela Therapeutics, Inc., formerly Sun Biopharma, a UF startup and clinical-stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients with cancer, has completed patient enrollment in its Phase 1 trial evaluating the safety and tolerability of SBP-101 when used in combination with standard of care agents gemcitabine and nab-paclitaxel for first-line treatment of patients with metastatic pancreatic ductal adenocarcinoma (PDA).